Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Change Imperative: Finding the right balance as times change

Posted on March 27th, 2017 by in Pharmacovigilance

I was delighted to chair a CPD Pharmacovigilance meeting last week in Berlin. I had been asked to share perspectives from the discussions within the Pharmaceutical Special Interest group at the Chartered Institute of Ergonomics and Human Factors. Continue reading “The Change Imperative: Finding the right balance as times change” »

What do Pharmacovigilance and Market Research Programs have in common?

Posted on September 2nd, 2016 by in Pharmacovigilance

If you want an example of why PV needs to be very closely involved in Patient Support Programs (PSP) or Market Research Programs (MRP), what happened recently to a very large pharmaceutical company should be a wake-up call for checking where you are on this topic. Continue reading “What do Pharmacovigilance and Market Research Programs have in common?” »

EMA Yearly Update on MLM – highlights and next steps

Posted on January 19th, 2016 by in Pharmacovigilance

EMA  Pharmacovigilance Programme Update Issue 6 – Preparing for Business Change

Since July 2014, EMA provides quarterly Pharmacovigilance Programme Updates to Marketing Authorisation Holders (MAHs). Continue reading “EMA Yearly Update on MLM – highlights and next steps” »

  1. 1
  2. 2